17
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Anti-angiogenesis: A new potential strategy to inhibit restenosis

Pages 3-6 | Published online: 10 Jul 2009

  • Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
  • Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
  • Kwon HM, Sangiorgi G, Ritman EL, et al. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by microscopic three dimensional computed tomography technique. J Am Coll Cardiol 1998; 32: 2072-2079.
  • Hausner EA, Orsini JA, Foster EL, et al. Vascular endothelial growth factor in porcine coronary arteries following balloon angioplasty. J Invest Surg 1999; 12: 15-23.
  • Pisco JM, Correla M, Esperance-pina JA, de Sousa EA. Vasa vasorum changes following stent placement in experimental arterial stenosis. J Vase Intervent Radiol 1993; 4: 269-273.
  • Kumamoto M, Makashima Y, Sueishi K. Intimai neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995; 26: 450-456.
  • Kwon HM, Sangiorgi G, Ritman EL, et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998; 101: 1551-1556.
  • Kamat BR, Galli SJ, Barger CA, Lainey EE, Silverman KJ. Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologie analysis. Hum Pathol 1987; 18: 1036-1042.
  • O'Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronaiy atherosclerotic plaques. Am J Pathol 1994; 145: 883-894.
  • Williams JK, Armstrong ME, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries: response to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988; 62: 515-523.
  • Köster W. Endarteritis and arteritis. Bed Klin Wochenschr 1876; 13: 454-455.
  • Winternitz MC, Thomas RM, LeCompte PM. The biology of arteriosclerosis. Springfield, IL, Charles C Thomas, 1938.
  • Barger CA, Beeuwkes III R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310: 175-177.
  • Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50.
  • Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998; 23: 529-532.
  • Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
  • Semenza GL, Agani F, lyer N, et al. Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology. Chest 1998; 114: 40S-45S.
  • Couper LL, Biyant SR, Eldrup-Jorgensen J, Bredenberg CE, Lindner V. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res 1997; 81: 932-939.
  • Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-2116.
  • Chen YX, Nakashima Y, Tanaka K, et al. lmmunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vase Biol 1999; 19: 131-139.
  • Hughes SE, Crossman D, Hall PA. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 1993; 27: 1214-1219.
  • Wysocki SJ, Zheng MH, Smith A, Norman PE. Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig. Eur J Vase Endovasc Surg 1998; 15: 225-230.
  • Bjornheden T, Eevin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vase Biol 1999; 19: 870-876.
  • Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967; 20: 409-421.
  • Stavri GT, Zachaiy IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995; 92: 11-14.
  • Pels K, Labinaz M, Hoffert C, O'Brien ER. Adventitial angiogenesis after coronary angioplasty: correlation with arterial remodeling. Arterioscler Thromb Vase Biol 1999; 19: 229-238.
  • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13:9-22.
  • Gorog P, Kovacs IB. Inhibition of vascular smooth muscle cell migration by intact endothelium is nitric oxide-mediated: interference by oxidised low density lipoproteins. J Vase Res 1998; 35: 165-169.
  • Asahara T, Banters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793-2801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.